Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Saranya Kakumanu"'
Autor:
Sergio D. Bergese, Alberto A. Uribe, Alexandre B. Todeschini, Grace Musto, Christine Mau, Mohit Sharma, Tumul Chowdhury, Kristen Gray, Derek S. Tsang, Lashmi Venkatraghavan, Catherine Caldwell, Seyed A Mansouri, Saranya Kakumanu, Sarah McNutt, Noa Farou, Oliver Bucher, Gelareh Zadeh, Emad Al Azazi, Casey Ryan, Patrick Bergquist
Publikováno v:
Journal of Neurosurgical Anesthesiology. 34:392-400
BACKGROUND High-grade gliomas impose substantial morbidity and mortality due to rapid cancer progression and recurrence. Factors such as surgery, chemotherapy and radiotherapy remain the cornerstones for treatment of brain cancer and brain cancer res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0bb42036b560b1ec123c0e13b5513cf
https://doi.org/10.1097/ana.0000000000000778
https://doi.org/10.1097/ana.0000000000000778
Autor:
Salem Alfaifi, Julian Kim, Shrinivas Rathod, William Hunter, Ahmet Leylek, Naseer Ahmed, Sankar Venkataraman, Niranjan Venugopal, Bill Kane, Amitava Chowdhury, Arbind Dubey, Gokulan Sivananthan, Saranya Kakumanu, Bashir Bashir
Publikováno v:
Radiotherapy and Oncology. 174:S16
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a068e801b036f91abb6e4f48c50105d
https://doi.org/10.1016/s0167-8140(22)04310-9
https://doi.org/10.1016/s0167-8140(22)04310-9
Publikováno v:
Journal of neurosurgical anesthesiology. 34(2)
There are many established factors that influence glioma progression, including patient age, grade of tumor, genetic mutations, extent of surgical resection, and chemoradiotherapy. Although the exposure time to anesthetics during glioma resection sur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7dd877cbaa6b16b5eadf4271930c146
https://pubmed.ncbi.nlm.nih.gov/32658099
https://pubmed.ncbi.nlm.nih.gov/32658099
Autor:
Perry Dhaliwal, Saranya Kakumanu, Janice R. Safneck, Amanallah Montazeripouragha, Patricia M. Baker, Brian J. Schmidt, Marshall Pitz, Sherry Krawitz
Publikováno v:
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 46:369-371
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::834eae198d81a5803138ead943ee500f
https://doi.org/10.1017/cjn.2019.23
https://doi.org/10.1017/cjn.2019.23
Autor:
Elizabeth Eisenhauer, Ming-Sound Tsao, Jean Powers, David D. Eisenstat, Dongsheng Tu, Muhammad Salim, Marshall Pitz, Ankineedu Saranya Kakumanu, Suzanne Kamel-Reid, Jeremy A. Squire, Brian Thiessen, Jacob C. Easaw, Haji Chalchal, Mary MacNeil, Warren P. Mason, David R. Macdonald, Diana F. Hausman, Shantanu Banerji
Publikováno v:
Neuro-Oncology.
BACKGROUND Glioblastoma (GBM) is the most aggressive malignancy of the central nervous system in adults. Increased activity of the phosphatidylinositol-3-OH kinase (PI3K) signal transduction pathway is common. We performed a phase II study using PX-8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1dbc33297669106ea473ccc0ff137543
https://doi.org/10.1093/neuonc/nou365
https://doi.org/10.1093/neuonc/nou365
Autor:
Kylea Potvin, Eric Winquist, Richard Gregg, Kim N. Chi, Muhammad Zulfiqar, Susan Ellard, Bernhard J. Eigl, Lyly H. Le, Sebastien J. Hotte, Lesley Seymour, Scott North, Christina Canil, Ankineedu Saranya Kakumanu, Joseph D. Ruether, Ashley Theis, Dongsheng Tu, Christopher M. Booth
Publikováno v:
Journal of Clinical Oncology. 35:5021-5021
5021 Background: Pelareorep (REO) is an oncolytic virus with in vitro and in vivo activity in many cancers, including prostate. It has in vitro synergism with microtubule targeted agents especially taxanes. We undertook a clinical trial to evaluate R
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1110cb4229cb4cb4375a70d74790f340
https://doi.org/10.1200/jco.2017.35.15_suppl.5021
https://doi.org/10.1200/jco.2017.35.15_suppl.5021
Autor:
Marshall W. Pitz, Elizabeth A. Eisenhauer, Mary Valeria MacNeil, Brian Thiessen, David R. Macdonald, Jacob C. Easaw, David Daniel Eisenstat, Ankineedu Saranya Kakumanu, Jeremy Squire, Ming Sound Tsao, Suzanne Kamel-Reid, Aurelie Tassignon, Diana Felice Hausman, Warren P. Mason
Publikováno v:
Journal of Clinical Oncology. 31:2053-2053
2053 Background: Glioblastoma (GBM) is the most aggressive malignancy of the central nervous system. The majority have genetic changes that increase the activity of the phosphatidylinositol-3-OH kinase (PI3K) signal transduction pathway, critical for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8aa129ab9a335c3bbc4365de7498cabb
https://doi.org/10.1200/jco.2013.31.15_suppl.2053
https://doi.org/10.1200/jco.2013.31.15_suppl.2053
Autor:
Eric Winquist, Naveen S. Basappa, Susan Ellard, Ankineedu Saranya Kakumanu, Kim N. Chi, Elizabeth Eisenhauer, Aurelie Tassignon, Diana F. Hausman, Anna V. Tinker, Robyn Jane Macfarlane, Vikaash Kumar, Joseph D. Ruether, Deepu Mirchandani, Scott North, Anthony M. Joshua, Alison L. Allan, Sebastien J. Hotte, Richard Gregg, Vamsee Torri, Christian K. Kollmannsberger
Publikováno v:
Journal of Clinical Oncology. 31:5042-5042
5042 Background: PX-866 is an irreversible, pan-isoform inhibitor of Class I PI-3K. Mutations in PIK3CA and loss of PTEN activity lead to activation of AKT signaling; alterations in these genes occur frequently in prostate cancers while activation of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a0f4f3880d2d0449add2f95b9b2bf5c0
https://doi.org/10.1200/jco.2013.31.15_suppl.5042
https://doi.org/10.1200/jco.2013.31.15_suppl.5042
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Brian Thiessen, Wendy Walsh, Joana Sederias, Jeremy A. Squire, Marshall Pitz, Elizabeth Eisenhauer, Mary MacNeil, Ming-Sound Tsao, David R. Macdonald, Ankineedu Saranya Kakumanu, Warren P. Mason, Suzanne Kamel-Reid
Publikováno v:
Journal of Clinical Oncology. 30:2051-2051
2051 Background: Glioblastoma (GBM) is the most aggressive malignancy of the central nervous system. The majority of GBM have genetic changes that increase the activity of the phosphatidylinositol-3-OH kinase (PI3K) signal transduction pathway, criti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5b86dc7caff78243de2ddc38b5b7fe4e
https://doi.org/10.1200/jco.2012.30.15_suppl.2051
https://doi.org/10.1200/jco.2012.30.15_suppl.2051